Metabolism of administered triethylene tetramine dihydrochloride in humans

This publication has 16 references indexed in Scilit:

• Effects of Some Chelating Agents on Urinary Copper Excretion by the Rat
  Chemical Research in Toxicology, 1995
• Fate of Orally Administered Triethylenetetramine Dihydrochloride: A Therapeutic Drug for Wilson's Disease.
  The Tohoku Journal of Experimental Medicine, 1993
• Acquired sideroblastic anaemia during treatment of Wilson's disease with triethylene tetramine dihydrochloride
  British Journal of Haematology, 1993
• Mode of action of triethylenetetramine dihydrochloride on copper metabolism in Wilson's disease
  Acta Neurologica Scandinavica, 1991
• A comparison of the effects of Penicillamine, Trientine, and trithiomolybdate on [35S]-labeled metallothionein in vitro; implications for Wilson's disease therapy
  Journal of Inorganic Biochemistry, 1991
• Triethylene-Tetramine(Trien) Therapy for Wilson's Disease.
  The Tohoku Journal of Experimental Medicine, 1991
• Treatment of Wilsonʼs Disease with Triethylene Tetramine Hydrochloride (Trientine)
  Journal of Pediatric Gastroenterology and Nutrition, 1990
• Wilson’s Disease: An Update, with Emphasis on New Approaches to Treatment
  Digestive Diseases, 1989
• The Use of Trientine in Preventing the Effects of Interrupting Penicillamine Therapy in Wilson's Disease
  New England Journal of Medicine, 1987
• MANAGEMENT OF PENICILLAMINE NEPHROPATHY IN WILSON'S DISEASE: A NEW CHELATING AGENT
  The Lancet, 1969